You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

5182 Results
Document
Jan 2022
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    entrectinib - For the treatment of locally advanced (not amenable to curative therapy) or metastatic NSCLC, according to clinical criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
entrectinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2024
Guidelines and Advice
Status: Current
ID: PET 2021-1
Jan 2022
Document
Feb 2022
Document
Feb 2022
Cancer facts
Feb 2022
Document
Feb 2022
Cancer facts
Feb 2022
Document
Feb 2022
Document
Feb 2022

Pages